The XJO is expected to open lower this morning following a pullback in the U.S overnight. They managed to break lower and hold their lows, and their futures are marginally in the red. Our muted open is likely due to large portion of their selling coming from tech, which is not overly represented in our
Read More
Even after its cost-cutting initiatives proved helpful, tutoring firm Cluey (ASX: CLU) has been dealing with setbacks in the face of reduced household budgets. The Company reported a 17% decline in revenue, with earnings taking a hit. In Q1 FY24, the EdTech company made notable improvements in its financial performance in other areas. The Company
Read More
While most companies create grand plans to enter the US, online wagering company PointsBet (ASX: PBH) is glad to wash its hand off its American arm since selling it off to Fanatics Betting and Gaming in August 2023. With the first installment of $275.4 million being received, PointsBet is finally focusing on its Australian and
Read More
Loyalty pays. Just ask IncentiaPay (ASX: INP) which has firmly rejected an unsolicited takeover proposal from a Melbourne-based loyalty and rewards program operator with a focus on the dining sector. The indicative offer, made on October 20, 2023, sought to acquire 100% of the IncentiaPay’s shares for a cash value of $0.0049 per share. INP
Read More
The XJO is expected to open marginally higher despite a strong bounce from key support in the U.S last night. Their futures are flat, which may help explain our muted open, but it is more likely that our market is simply being cautious heading into the CPI reading today. Our market has also been rather
Read More
Syntara – it’s a name that biotech investors will be hearing a lot in the years to come with the Company set to accelerate clinical development of its novel drugs to treat blood cancers. Syntara* will be the new name for Pharmaxis (ASX: PXS) which has sold its mannitol respiratory business and is pursuing an
Read More